Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-27

Clinical Trial Update: Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study evaluating two Japanese encephalitis vaccines (ChimeriVax-JE and JE Inactivated Mouse Brain Vaccine) in children, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ChimeriVax-JE (live attenuated Japanese encephalitis vaccine)
  • JE Inactivated Mouse Brain Vaccine (inactivated mouse brain vaccine for Japanese encephalitis)

Snippet

Sponsor: Sanofi | Conditions: Japanese Encephalitis | Phase 2 | Status: COMPLETED | Results posted: 2012-08-27